IRIS
SPINA, Edoardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.585
EU - Europa 17.696
AS - Asia 9.170
SA - Sud America 3.248
Continente sconosciuto - Info sul continente non disponibili 449
AF - Africa 267
OC - Oceania 26
Totale 53.441
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.004
RU - Federazione Russa 8.288
SG - Singapore 3.895
BR - Brasile 2.803
CN - Cina 2.502
IE - Irlanda 2.092
IT - Italia 1.703
SE - Svezia 1.693
HK - Hong Kong 1.004
DE - Germania 912
UA - Ucraina 910
FR - Francia 545
VN - Vietnam 524
FI - Finlandia 456
GB - Regno Unito 444
IN - India 349
CA - Canada 263
PL - Polonia 214
AR - Argentina 152
BD - Bangladesh 146
MX - Messico 112
TR - Turchia 92
NL - Olanda 89
IQ - Iraq 87
EC - Ecuador 75
ID - Indonesia 73
ZA - Sudafrica 73
BE - Belgio 62
JP - Giappone 61
CO - Colombia 60
ES - Italia 58
PK - Pakistan 54
UZ - Uzbekistan 51
VE - Venezuela 49
MA - Marocco 46
CL - Cile 44
AT - Austria 42
CR - Costa Rica 42
EE - Estonia 37
AE - Emirati Arabi Uniti 31
PH - Filippine 31
JM - Giamaica 28
SA - Arabia Saudita 28
DZ - Algeria 26
KE - Kenya 23
MY - Malesia 23
AZ - Azerbaigian 22
EG - Egitto 22
TN - Tunisia 22
UY - Uruguay 22
NP - Nepal 20
CI - Costa d'Avorio 19
HN - Honduras 19
JO - Giordania 19
NI - Nicaragua 19
TT - Trinidad e Tobago 19
AU - Australia 18
IL - Israele 18
KZ - Kazakistan 18
LT - Lituania 17
OM - Oman 17
AL - Albania 16
PY - Paraguay 16
SV - El Salvador 16
CZ - Repubblica Ceca 15
GR - Grecia 15
PE - Perù 15
BG - Bulgaria 12
CH - Svizzera 12
CW - ???statistics.table.value.countryCode.CW??? 12
IR - Iran 11
LB - Libano 11
TH - Thailandia 11
AM - Armenia 9
DO - Repubblica Dominicana 9
KG - Kirghizistan 9
PR - Porto Rico 9
RS - Serbia 9
BO - Bolivia 8
GP - Guadalupe 8
KR - Corea 8
LV - Lettonia 8
PS - Palestinian Territory 8
RO - Romania 8
SN - Senegal 8
PA - Panama 7
SC - Seychelles 7
EU - Europa 6
GE - Georgia 6
GT - Guatemala 6
TW - Taiwan 6
BN - Brunei Darussalam 5
BS - Bahamas 5
DK - Danimarca 5
ET - Etiopia 5
HR - Croazia 5
PT - Portogallo 5
BB - Barbados 4
BZ - Belize 4
GD - Grenada 4
Totale 52.930
Salva come PNG Salva come JPEG
Città #
Ashburn 2.755
Moscow 2.640
Singapore 2.131
Dublin 2.079
Dallas 1.846
Jacksonville 1.752
Chandler 1.511
Hong Kong 999
San Jose 937
Beijing 909
Council Bluffs 755
Nyköping 742
Los Angeles 437
Princeton 400
The Dalles 398
Cambridge 361
Dearborn 361
Lauterbourg 348
New York 307
Des Moines 286
Medford 245
Boardman 239
Messina 234
São Paulo 213
Buffalo 205
Warsaw 196
Ann Arbor 194
Santa Clara 177
Ho Chi Minh City 170
Hyderabad 136
Munich 136
Tianjin 126
Wilmington 126
Atlanta 122
Milan 122
Rome 118
Houston 113
Hanoi 108
Orem 108
Guangzhou 98
Lancaster 95
Redondo Beach 94
San Francisco 88
Rio de Janeiro 86
Denver 83
Seattle 82
Woodbridge 78
Jinan 74
Montreal 72
Frankfurt am Main 71
Phoenix 70
Turku 68
Belo Horizonte 67
North Bergen 65
Brooklyn 64
Shenyang 64
Bremen 63
Chicago 63
Brasília 62
San Mateo 61
Brussels 57
Boston 49
Tokyo 49
Nanjing 48
Catania 47
Columbus 46
Curitiba 46
Pune 46
Tashkent 44
Chennai 42
London 40
Baghdad 38
Naples 38
Hangzhou 37
Johannesburg 36
Toronto 36
Hebei 34
Porto Alegre 34
Campinas 33
Mexico City 33
Haikou 32
Helsinki 32
Nuremberg 31
Washington 31
Shenzhen 30
Zhengzhou 30
San José 29
Stockholm 28
Norwalk 27
Shanghai 27
Dhaka 26
Ningbo 26
Quito 26
Taizhou 26
Turin 26
Amsterdam 25
Guarulhos 25
Haiphong 25
Manchester 25
Mumbai 25
Totale 27.995
Salva come PNG Salva come JPEG
Nome #
Clinically Relevant Drug Interactions Between Statins and Antidepressants 900
Drug-drug interactions between psychotropic medications and oral contraceptives 849
Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics. 547
Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents 483
Efficacia di un trattamento aggiuntivo con olanzapina nel disturbo ossessivo-compulsivo resistente agli SSRI 456
Rabeprazole and psychiatric symptoms. 392
Cutis verticis gyrata primitiva o pachidermia verticis gyrata: contributo clinico-istologico 345
Serenoa repens as an Endocrine Disruptor in a 10-Year-Old Young Girl: A New Case Report 343
Safety and Tolerability of Antipsychotic Drugs in Pediatric Patients: Data From a 1-Year Naturalistic Study 318
Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study 300
Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: A clinically relevant pharmacokinetic drug interaction 295
Adverse Drug Reactions in Hospitalized patients: results of the FORWARD (Facilitation of reporting in hospital Ward) study. 290
Short-term memory loss associated with rosuvastatin. 278
Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System 269
A molecular pathway analysis informs the genetic background at risk for schizophrenia. 262
Vortioxetine on Cognition in Schizophrenia: A Pilot Study 255
6-Mer Hyaluronan Oligosaccharides ModulateNeuroinflammation and a-Synuclein Expression inNeuron-Like SH-SY5Y Cells 247
Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database 242
A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children 237
A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults. 236
Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study 236
Acute Cerebellar Ataxia Following Meningococcal Group C Conjugate Vaccination 227
Aripiprazolo in bambini con ADHD in comorbidità con Disturbo da Tic 222
Confronto Teofillina-Doxofillina nella risoluzione del broncospasmo 221
Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database 220
Management of women with epilepsy: from preconception to post-partum 215
Clinically significant drug interactions with newer antidepressants. 215
Clinically relevant drug interactions between newer antidepressants and oral anticoagulants 213
"Valproic acid-amitriptyline interaction in man 208
Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 207
Drug-induced urinary retention: an analysis of a national spontaneous adverse drug reaction reporting database 207
Augmentation con Lamotrigina in pazienti con schizofrenia resistente in trattamento con Clozapina 204
6-MERS HYALURONAN OLIGOSACCHARIDES STIMULATE INFLAMMATORY RESPONSE IN NEURONAL-LIKE DIFFERENTIATED SH-SY5Y NEUROBLASTOMA CELLS 204
Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder 204
ECG parameters in children and adolescents treated with aripiprazole and risperidone 203
A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting risperidone. 203
ANTITHETIC ACTION OF HYALURONAN 6-MER IN UNDIFFERENTIATED AND DIFFERENTIATED SH-SY5Y CELLS 202
Tossicità cardiovascolare degli antipsicotici atipici in età evolutiva 201
Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data 201
Ototoxic adverse drug reactions: A disproportionality analysis using the Italian spontaneous reporting database 199
Low-dose of bergamot-derived polyphenolic fraction (BPF) did not improve metabolic parameters in second generation antipsychotics-treated patients: Results from a 60-days open-label study 198
Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care 197
Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity 196
Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. 196
Generic Olanzapine Substitution in Patients with Schizophrenia: Assessment of Serum Concentrations and Therapeutic Response After Switching 196
Aripiprazole in Children with Multiple-complex Developmental Disorder (McDD): a case series. 194
Antidepressant use in the elderly: The role of pharmacodynamics and pharmacokinetics in drug safety 193
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database 192
Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder 191
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project 189
Antidepressant effect of hypericum perforatum extract on behaviour and neurogenesis in chronic corticosterone-treated mice. 189
ABCB1 polymorphisms influence steady state plasma levels of 9-hydroxyrisperidone and risperidone active moiety. 188
Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 184
Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. 182
Augmentation of clozapine with agomelatine in partial-responder schizophrenia: A 16-week, open-label, uncontrolled pilot study 182
Aripiprazole in Children with Multiple-complex Developmental Disorder (McDD): a case series. 180
Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study. 180
Efficacia e tollerabilità della quetiapina vs. clozapina in pazienti anziani parkinsoniani con psicosi dopaminergica. 179
Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients 179
Aripiprazole enhances the antidepressant effect of fluoxetine in mice. 178
Effects of aripiprazole and risperidone on ventricular repolarization in children and adolescent. 178
Real world use of biological drugs in patients with psoriasis/psoriatic arthritis: a retrospective, population-based study from Southern Italy in the years 2010-2014 178
Antidepressant drugs and seizure susceptibility: From in vitro data to clinical practice 177
Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population 177
Risperidone treatment of children with autistic disorder: Effectiveness, tolerability, and pharmacokinetic implications 177
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database 174
Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. XVII Congresso Nazionale della Società Italiana di Neuropsicofarmacologia, Cagliari 22-25 Settembre 2010, p. 47. 173
PATTERN PRESCRITTIVO DI FARMACI ANTIEPILETTICI NELL'ANZIANO: STUDIO DI POPOLAZIONE IN UN'AREA DEL SUD ITALIA NEGLI ANNI 2004-2007 172
Aripiprazole enhances the antidepressat effect of fluoxetine in mice. 172
A double-blind comparative study of bromperidol versus halperidol in schizophrenic patients 172
A pharmacokinetic-pharmacodynamic method for predicting warfarin maintenance dose: preliminary results 171
Clinically Relevant Drug Interactions with Anti-Alzheimer's Drugs. 171
Safety and tolerability of antipsychotic drugs in pediatric patients: data from an ongoing active pharmacovigilance study in Sicily 171
Pediatric adverse reactions to antiseizure medications – An analysis of data from the Italian spontaneous reporting system (2001–2019) 171
AN ENDOCRINOLOGIC STUDY OF PATIENTS WITH PRIMARY-CUTIS-VERTICIS GYRATA 170
Effetto di un trattamento con risperidone o olanzapina sui livelli serici di prolattina in bambini e adolescenti con patologie psichiatriche. 170
Aripiprazole augmentation of serotinin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study 170
A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. 170
Effectiveness and safety profile of dupilumab in chronic Rhinosinusitis with nasal polyps: real-life data in tertiary care 169
No association between CYP2D6 polymorphism and Alzheimer's disease in an Italian population 166
5-HT2A and 5-HT2C receptor polymorphisms and psychotic symptoms in Alzheimer's disease 165
Acute cerebellar ataxia following meningococcal group C conjugate vaccination 165
“Newer and older antiepileptic drug in southern Italy: a population based study during the years 2003-2005” 164
Biosimilars in Pediatric Inflammatory Bowel Diseases: A Systematic Review and Real Life-Based Evidence 164
Age-related changes in pharmacodynamics: focus on drug acting on cetral nervous and cardiovascular systems 163
Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial. 163
Early atypical injection-site reactions to COVID-19 vaccine: a case series 159
“Augmentation con Duloxetina vs. placebo in un campione di schizofrenici partial responders in trattamento stabilizzato con antipsicotici atipici”. 158
Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: A follow-up of two years 157
Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005. 157
Red Yeast Rice (RYR) supplementation in patients treated with second-generation antipsychotics. 157
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study 157
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety 157
Estimating the effects of co-medications on plasma olanzapine concentrations by using a mixed model. 156
Neuropsychiatric reactions to drugs: an analysis of spontaneous reports from general practitioners in Italy. 156
Effect of topiramate on plasma concentrations of clozapine, olanzapine, risperidone, and quetiapine in patients with psychotic disorders 155
Prescribing pattern of antiepileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-2007 155
Augmentation of Clozapine With Ziprasidone in Refractory Schizophrenia: A Double-Blind, Placebo-Controlled Study. 155
Caratterizzazione delle reazioni avverse a farmaci segnalate da un reparto di Allergologia e Immunologia Clinica 154
Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies 154
Totale 22.139
Salva come PNG Salva come JPEG
Categoria #
all - tutte 175.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 175.736
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.929 0 0 0 75 49 23 132 113 81 446 291 719
2022/20235.860 506 407 217 477 518 540 51 343 2.536 28 175 62
2023/20241.660 121 244 108 167 167 334 70 102 26 163 19 139
2024/20257.210 96 95 155 399 380 219 137 1.636 1.923 445 578 1.147
2025/202620.855 903 1.405 1.795 1.467 1.586 4.503 2.395 2.465 2.561 890 418 467
2026/20278.193 996 2.630 2.168 2.399 0 0 0 0 0 0 0 0
Totale 53.441